HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Youko Suehiro Selected Research

Radioimmunotherapy

10/2014Factors associated with effects of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Youko Suehiro Research Topics

Disease

10Lymphoma (Lymphomas)
05/2022 - 07/2003
9Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2022 - 04/2013
7Neoplasms (Cancer)
12/2022 - 05/2005
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 06/2019
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2022 - 02/2003
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2021 - 07/2003
3Thrombocytopenia (Thrombopenia)
02/2021 - 09/2002
3Multiple Myeloma
01/2021 - 02/2003
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2020 - 09/2002
3Hemorrhage
03/2020 - 01/2016
2Infections
12/2022 - 06/2012
2B-Cell Lymphoma (Lymphoma, B Cell)
05/2022 - 06/2019
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 10/2014
2T-Cell Lymphoma (Lymphoma, T Cell)
07/2020 - 01/2004
1Communicable Diseases (Infectious Diseases)
12/2022
1Hematologic Neoplasms (Hematological Malignancy)
12/2022
1Body Weight (Weight, Body)
05/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Philadelphia Chromosome
01/2022
1Residual Neoplasm
01/2022
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022
1Neutropenia
02/2021
1Lymphopenia (Lymphocytopenia)
02/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2019
1Peripheral Nervous System Diseases (PNS Diseases)
06/2018
1Hodgkin Disease (Hodgkin's Disease)
01/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016
1Aplastic Anemia (Anemia, Hypoplastic)
01/2016
1Liver Diseases (Liver Disease)
01/2016
1Bone Marrow Failure Disorders
01/2016
1Peliosis Hepatis
01/2016
1Disseminated Intravascular Coagulation
01/2016
1Liver Failure
01/2016
1Second Primary Neoplasms (Neoplasms, Second)
10/2014
1Primary Effusion Lymphoma
07/2014
1T-Cell Leukemia (Leukemia, T Cell)
04/2013
1Inflammation (Inflammations)
02/2011
1Colitis
02/2011
1Graves Disease (Basedow Disease)
02/2008
1Agranulocytosis (Granulocytopenia)
02/2008
1Hyperthyroidism
02/2008
1Pancytopenia
02/2008
1Splenomegaly
02/2008

Drug/Important Bio-Agent (IBA)

7Prednisolone (Predate)FDA LinkGeneric
01/2022 - 09/2002
6Rituximab (Mabthera)FDA Link
12/2022 - 07/2014
4mogamulizumabIBA
10/2022 - 01/2019
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2018
4Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 06/2018
3Bendamustine HydrochlorideFDA Link
12/2022 - 07/2021
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 06/2018
3Etoposide (VP 16)FDA LinkGeneric
12/2020 - 07/2014
3Tryptophan (L-Tryptophan)FDA Link
12/2020 - 02/2011
2Immunoglobulin G (IgG)IBA
12/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2021
2Pharmaceutical PreparationsIBA
02/2021 - 06/2012
2Prednisone (Sone)FDA LinkGeneric
01/2021 - 06/2018
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2020 - 04/2018
2Inosine Triphosphate (ITP)IBA
03/2020 - 04/2018
2VaccinesIBA
03/2019 - 05/2015
1parsaclisibIBA
05/2022
1Dasatinib (BMS 354825)FDA Link
01/2022
1Imatinib Mesylate (Gleevec)FDA Link
01/2022
1polatuzumab vedotinIBA
07/2021
1darinaparsinIBA
02/2021
1Adenosine Monophosphate (AMP)IBA
01/2021
1Melphalan (Alkeran)FDA LinkGeneric
01/2021
1Bortezomib (Velcade)FDA Link
01/2021
1Poly I-CIBA
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2021
1Adenosine (Adenocard)FDA LinkGeneric
01/2021
1Indicators and Reagents (Reagents)IBA
12/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2020
1Monoclonal AntibodiesIBA
06/2019
1inebilizumabIBA
06/2019
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2018
1Dacarbazine (DIC)FDA LinkGeneric
01/2016
1SteroidsIBA
01/2016
1Danazol (Azol)FDA LinkGeneric
01/2016
1leucyl- leucyl- phenylalanyl- glycyl- tyrosyl- prolyl- valyl- tyrosyl- valineIBA
05/2015
1sobuzoxaneIBA
07/2014
1EpitopesIBA
04/2013
1Thrombopoietin (c-mpl Ligand)IBA
06/2012
1Interleukin-12 (IL 12)IBA
02/2011
1Serotonin (5 Hydroxytryptamine)IBA
02/2011
1CytokinesIBA
02/2011
1Dextran SulfateIBA
02/2011
1LipopolysaccharidesIBA
02/2011
1Methimazole (Thiamazole)FDA LinkGeneric
02/2008
1Interleukin-2 Receptors (IL 2 Receptor)IBA
02/2008

Therapy/Procedure

8Therapeutics
12/2022 - 09/2002
5Drug Therapy (Chemotherapy)
12/2022 - 09/2002
5Hematopoietic Stem Cell Transplantation
01/2022 - 06/2012
5Stem Cell Transplantation
07/2021 - 01/2019
3Aftercare (After-Treatment)
10/2014 - 12/2003
2Cell Transplantation
12/2021 - 07/2003
1Induction Chemotherapy
10/2020
1Autologous Transplantation
10/2020
1Remission Induction
06/2018
1Radioimmunotherapy
10/2014
1Thyroidectomy
02/2008